Sparstolonin B inhibits pancreatic adenocarcinoma through the NF-κB signaling pathway

alexandrossfakianakis shared this article with you from Inoreader Sparstolonin B inhibits pancreatic adenocarcinoma through the NF-κB signaling pathway via ScienceDirect Publication: Experimental Cell Research Publication date: Available online 18 May 2022 Source: Experimental Cell Research Author(s): Yang Lyu, Bowen Duan, Ziming Liu, Fan Yang, Chen Chen, Xuejiao Jiang, Xiang Liu View on Web

Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.